A study to monitor adverse drug reaction profile of theophylline in patients of obstructive airway disease Kavita Gulati , N Tyagi, G Vishnoi, VK Vijayan, A Ray Department of Pharmacology & Clinical Research Centre, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi-110 007 Pharmacovigilance and Drug Safety Conference (SOPI-2006), Bangalore, 11-12 November 2006
21
Embed
A study to monitor adverse drug reaction profile of theophylline in patients of obstructive airway disease Kavita Gulati, N Tyagi, G Vishnoi, VK Vijayan,
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
A study to monitor adverse drug reaction profile of theophylline in patients of obstructive airway
disease
Kavita Gulati, N Tyagi, G Vishnoi, VK Vijayan, A Ray
Department of Pharmacology & Clinical Research Centre, Vallabhbhai Patel Chest Institute, University of
Delhi, Delhi-110 007
Pharmacovigilance and Drug Safety Conference (SOPI-2006), Bangalore,
11-12 November 2006
Introduction• Respiratory diseases : a major cause of
hospital admissions
• Obstructive airway disease (Bronchial Asthma and COPD) affect 5-7% population in industrialized countries
• Several factors (allergy and smoking) contribute to their genesis
• Optimization and rationalization of drug therapy : key to effective management
• Bronchodilators and corticosteroids are the mainstay in the treatment of these conditions
• Theophylline : Emerging as an important adjuvant in the treatment of bronchial asthma and COPD
• Combination with other drugs has synergistic effects in many situations
• Theophylline : A drug of herbal origin (Camellia sinensis – tea plant)
• Widely used earlier as bronchodilator
• Pharmacoeconomically viable
• Narrow therapeutic index and has high propensity to induce toxicity, resulting in the restricted use
• Recently : A resurgence in the interest in theophylline
• Low doses (lower than those needed to induce bronchodilation) exert beneficial effects
• Anti-inflammatory and immunomodulatory effects reported
• Judicious use could be of benefit in obstructive airway disease in developing countries
• Adverse Drug Reactions : Noxious/untoward effects to drugs or chemicals given for therapeutic, preventive or diagnostic purposes
• Common with drugs with narrow safety margin
• Mostly preventable
• Knowledge of PK-PD of the drug crucial
• ADR monitoring and TDM important exercises
Objectives
• To monitor adverse drug reactions (ADRs) with theophylline in patients of bronchial asthma and COPD attending the OPD of Vallabhbhai Patel Chest Institute, Delhi
• Predict strategies to rationalize drug therapy with theophylline in such patients with obsturctive airway disease
Methods
• Subjects : OPD patients of bronchial asthma and COPD
• Prospective study
• Ethical clearance obtained
• ADR profile recorded as per proforma for the National Pharmacovigilance Programme
• Causality assessment : Naranjo`s scale (1981)
To assess the adverse drug reaction, please answer the following questionnaire and give the pertinent score.
Yes No Do Not Know Score1. Are there previous conclusive reports on
this reaction?+1 0 0 ____
2. Did the adverse event appear after thesuspected drug was administered?
+2 -1 0 ____
3. Did the adverse reaction improve when thedrug was discontinued or a specificantagonist was administered?
+1 0 0 ____
4. Did the adverse reactions appear when thedrug was readministered?
+2 -1 0 ____
5. Are there alternative causes (other than thedrug) that could on their own have causedthe reaction?
-1 +2 0 ____
6. Did the reaction reappear when a placebowas given?
-1 +1 0 ____
7. Was the drug detected in the blood (orother fluids) in concentrations known to betoxic?
+1 0 0 ____
8. Was the reaction more severe when thedose was increased, or less severe when thedose was decreased?
+1 0 0 ____
9. Did the patient have a similar reaction tothe same or similar drugs in any previousexposure?
+1 0 0 ____
10. Was the adverse event confirmed by anyobjective evidence?